BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37009722)

  • 21. Detection of SARS-CoV-2-Specific Antibodies in Human Breast Milk and Their Neutralizing Capacity after COVID-19 Vaccination: A Systematic Review.
    Nicolaidou V; Georgiou R; Christofidou M; Felekkis K; Pieri M; Papaneophytou C
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
    Scaggs Huang F
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Counseling in maternal-fetal medicine: SARS-CoV-2 infection in pregnancy.
    Di Mascio D; Buca D; Berghella V; Khalil A; Rizzo G; Odibo A; Saccone G; Galindo A; Liberati M; D'Antonio F
    Ultrasound Obstet Gynecol; 2021 May; 57(5):687-697. PubMed ID: 33724545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breastfeeding Women's Attitudes About the SARS-COV-2 Vaccine in Spain.
    Alfaro Blazquez R; González-Timoneda A; González-Timoneda M; Gómez Gómez M; Borrull-Guardeño J
    J Hum Lact; 2022 Nov; 38(4):609-618. PubMed ID: 35848166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase in SARS-CoV-2 RBD-Specific IgA and IgG Antibodies in Human Milk From Lactating Women Following the COVID-19 Booster Vaccination.
    Henle AM
    J Hum Lact; 2023 Feb; 39(1):51-58. PubMed ID: 36398916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.
    AlJamaan F; Temsah MH; Alhasan K; Alenezi S; Alhaboob A; Alrabiaah A; Batais M; Alshahrani F; Assiri RA; Bafaqih H; Alaraj A; Al Qadrah B; Alhaidary A; Saad K; Saddik B; Halwani R; Rabaan AA; Al-Subaie S; Barry M; Al-Tawfiq JA
    J Infect Public Health; 2022 Jul; 15(7):773-780. PubMed ID: 35728424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of maternal SARS-CoV-2 infection and COVID-19 vaccination on maternal-fetal outcomes.
    Piekos SN; Price ND; Hood L; Hadlock JJ
    Reprod Toxicol; 2022 Dec; 114():33-43. PubMed ID: 36283657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus Vaccination in Pregnancy: Implications for Maternal and Infant Immunity.
    Conti MG; Terreri S; Terrin G; Natale F; Pietrasanta C; Salvatori G; Brunelli R; Midulla F; Papaevangelou V; Carsetti R; Angelidou A
    Clin Infect Dis; 2022 Aug; 75(Suppl 1):S37-S45. PubMed ID: 35535796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic review of the safety, immunogenicity, and effectiveness of COVID-19 vaccines in pregnant and lactating individuals and their infants.
    Fu W; Sivajohan B; McClymont E; Albert A; Elwood C; Ogilvie G; Money D
    Int J Gynaecol Obstet; 2022 Mar; 156(3):406-417. PubMed ID: 34735722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of maternal SARS-CoV-2 booster vaccination on blood and breastmilk antibodies.
    Rick AM; Lentscher A; Xu L; Wilkins MS; Nasser A; Tuttle DJ; Megli C; Marques ETA; McElroy AK; Williams JV; Martin JM
    PLoS One; 2023; 18(6):e0287103. PubMed ID: 37310982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The psychological and behavioural correlates of COVID-19 vaccine hesitancy and resistance in Ireland and the UK.
    Walsh JC; Comar M; Folan J; Williams S; Kola-Palmer S
    Acta Psychol (Amst); 2022 May; 225():103550. PubMed ID: 35259642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attitudes Toward COVID-19 Illness and COVID-19 Vaccination among Pregnant Women: A Cross-Sectional Multicenter Study during August-December 2020.
    Battarbee AN; Stockwell MS; Varner M; Newes-Adeyi G; Daugherty M; Gyamfi-Bannerman C; Tita AT; Vorwaller K; Vargas C; Subramaniam A; Reichle L; Galang RR; Powers E; Lucca-Susana M; Parks M; Chen TJ; Razzaghi H; Dawood FS
    Am J Perinatol; 2022 Jan; 39(1):75-83. PubMed ID: 34598291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination Hesitancy and Conspiracy Beliefs in the UK During the SARS-COV-2 (COVID-19) Pandemic.
    Bacon AM; Taylor S
    Int J Behav Med; 2022 Aug; 29(4):448-455. PubMed ID: 34599463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 Vaccines during Pregnancy and Breastfeeding: A Systematic Review of Maternal and Neonatal Outcomes.
    De Rose DU; Salvatori G; Dotta A; Auriti C
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336947
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-SARS-CoV-2 antibodies in breast milk during lactation after infection or vaccination: A cohort study.
    Olearo F; Radmanesh LS; Felber N; von Possel R; Emmerich P; Pekarek N; Pfefferle S; Nörz D; Hansen G; Diemert A; Aepfelbacher M; Hecher K; Lütgehetmann M; Arck PC; Tallarek AC
    J Reprod Immunol; 2022 Sep; 153():103685. PubMed ID: 36029724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 fear, vaccination hesitancy, and vaccination status in pregnant and breastfeeding women in Turkey.
    Miral MT; Turgut N; Güldür A; Güloğlu ZE; Mamuk R
    Afr J Reprod Health; 2023 Jun; 27(6):60-69. PubMed ID: 37715675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of SARS-CoV-2 specific IgG and IgA antibodies in serum and milk with different SARS-COV-2 vaccines in lactating women.
    Lechosa-Muñiz C; Paz-Zulueta M; Irure-Ventura J; Mendez-Legaza JM; Cuesta González R; Gómez-Acebo I; López-Hoyos M; Llorca J; Cabero-Pérez MJ
    Int Breastfeed J; 2023 Jan; 18(1):3. PubMed ID: 36627706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnant and breastfeeding women's attitudes and fears regarding the COVID-19 vaccination.
    Schaal NK; Zöllkau J; Hepp P; Fehm T; Hagenbeck C
    Arch Gynecol Obstet; 2022 Aug; 306(2):365-372. PubMed ID: 34705115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 Vaccination in Pregnancy and Lactation: Current Research and Gaps in Understanding.
    Shook LL; Fallah PN; Silberman JN; Edlow AG
    Front Cell Infect Microbiol; 2021; 11():735394. PubMed ID: 34604115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.